Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform
Also known as: PIK3CG
Function
Phosphoinositide-3-kinase (PI3K) that phosphorylates PtdIns(4,5)P2 (Phosphatidylinositol 4,5-bisphosphate) to generate phosphatidylinositol 3,4,5-trisphosphate (PIP3). PIP3 plays a key role by recruiting PH domain-containing proteins to the membrane, including AKT1 and PDPK1, activating signaling cascades involved in cell growth, survival, proliferation, motility and morphology. Links G protein coupled receptor activation to PIP3 production. Involved in immune, inflammatory and allergic responses. Modulates leukocyte chemotaxis to inflammatory sites and in response to chemoattractant agents. May control leukocyte polarization and migration by regulating the spatial accumulation of PIP3 and by regulating the organization of F-actin formation and integrin-based adhesion at the leading edge. Controls motility of dendritic cells. Together with PIK3CD is involved in natural killer (NK) cell development and migration towards the sites of inflammation. Participates in T-lymphocyte migration. Regulates T-lymphocyte proliferation, activation, and cytokine production. Together with PIK3CD participates in T-lymphocyte development. Required for B-lymphocyte development and signaling. Together with PIK3CD participates in neutrophil respiratory burst. Together with PIK3CD is involved in neutrophil chemotaxis and extravasation. Together with PIK3CB promotes platelet aggregation and thrombosis. Regulates alpha-IIb/beta-3 integrins (ITGA2B/ ITGB3) adhesive function in platelets downstream of P2Y12 through a lipid kinase activity-independent mechanism. May have also a lipid kinase activity-dependent function in platelet aggregation. Involved in endothelial progenitor cell migration. Negative regulator of cardiac contractility. Modulates cardiac contractility by anchoring protein kinase A (PKA) and PDE3B activation, reducing cAMP levels. Regulates cardiac contractility also by promoting beta-adrenergic receptor internalization by binding to GRK2 and by non-muscle tropomyosin phosphorylation. Also has serine/threonine protein kinase activity: both lipid and protein kinase activities are required for beta-adrenergic receptor endocytosis. May also have a scaffolding role in modulating cardiac contractility. Contributes to cardiac hypertrophy under pathological stress. Through simultaneous binding of PDE3B to RAPGEF3 and PIK3R6 is assembled in a signaling complex in which the PI3K gamma complex is activated by RAPGEF3 and which is involved in angiogenesis. In neutrophils, participates in a phospholipase C-activating N-formyl peptide-activated GPCR (G protein-coupled receptor) signaling pathway downstream of RASGRP4-mediated Ras-activation, to promote neutrophil functional responses (By similarity).
Classification
- Family (Pfam)
- PF00454 PI3_PI4_kinase, PF00792 PI3K_C2, PF00794 PI3K_rbd, PF00613 PI3Ka, PF19710 PIK3CG_ABD
- InterPro
- ARM-type_fold, C2_domain_sf, Kinase-like_dom_sf, PI3/4_kinase, PI3/4_kinase_cat_dom, PI3/4_kinase_cat_sf, PI3/4_kinase_CS, PI3K-type_C2_dom, PI3K_ABD, PI3K_accessory_dom, PI3K_accessory_sf, PI3K_Ras-bd_dom, PIK3CG_ABD, Ubiquitin-like_domsf
- Functional cluster
- Zinc-Finger & Ubiquitination Proteins
Experimental structures · PDB · 107
- 1E8Y X-ray 2.00A
- 1E8Z X-ray 2.40A
- 1HE8 X-ray 3.00A
- 2A4Z X-ray 2.90A
- 2A5U X-ray 2.70A
- 2CHW X-ray 2.60A
- 2CHX X-ray 2.50A
- 2CHZ X-ray 2.60A
- 2V4L X-ray 2.50A
- 3APC X-ray 2.54A
- 3APD X-ray 2.55A
- 3APF X-ray 2.82A
- … and 95 more
A predicted model is available from AlphaFold.
Gene Ontology · 47
- GO:0005737 cytoplasm
- GO:0005829 cytosol
- GO:0016020 membrane
- GO:0005943 phosphatidylinositol 3-kinase complex, class IA
- GO:0005944 phosphatidylinositol 3-kinase complex, class IB
- GO:0005886 plasma membrane
- GO:0016303 1-phosphatidylinositol-3-kinase activity
- GO:0046934 1-phosphatidylinositol-4,5-bisphosphate 3-kinase activity
- GO:0035005 1-phosphatidylinositol-4-phosphate 3-kinase activity
- GO:0005524 ATP binding
- GO:0046875 ephrin receptor binding
- GO:0042802 identical protein binding
- GO:0004672 protein kinase activity
- GO:0106310 protein serine kinase activity
- GO:0004674 protein serine/threonine kinase activity
- GO:0002250 adaptive immune response
- GO:0001525 angiogenesis
- GO:0016477 cell migration
- GO:0002407 dendritic cell chemotaxis
- GO:0006897 endocytosis
- GO:0007186 G protein-coupled receptor signaling pathway
- GO:0006955 immune response
- GO:0006954 inflammatory response
- GO:0045087 innate immune response
- GO:0043303 mast cell degranulation
- GO:0035747 natural killer cell chemotaxis
- GO:0055118 negative regulation of cardiac muscle contraction
- GO:0030593 neutrophil chemotaxis
- GO:0072672 neutrophil extravasation
- GO:0043491 phosphatidylinositol 3-kinase/protein kinase B signal transduction
- GO:0046854 phosphatidylinositol phosphate biosynthetic process
- GO:0036092 phosphatidylinositol-3-phosphate biosynthetic process
- GO:0048015 phosphatidylinositol-mediated signaling
- GO:0007200 phospholipase C-activating G protein-coupled receptor signaling pathway
- GO:0070527 platelet aggregation
- GO:0001819 positive regulation of cytokine production
- GO:0010595 positive regulation of endothelial cell migration
- GO:0043406 positive regulation of MAP kinase activity
- GO:0051897 positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
- GO:0035022 positive regulation of Rac protein signal transduction
- GO:0045765 regulation of angiogenesis
- GO:0033628 regulation of cell adhesion mediated by integrin
- GO:0002679 respiratory burst involved in defense response
- GO:0003376 sphingosine-1-phosphate receptor signaling pathway
- GO:0042110 T cell activation
- GO:0010818 T cell chemotaxis
- GO:0042098 T cell proliferation
Disease associations
- immunodeficiency 97 with autoinflammation MONDO:0030717
Drugs targeting this protein · 27
- PF-04691502 inhibitor
- OMIPALISIB inhibitor
- IZORLISIB inhibitor
- DACTOLISIB inhibitor
- APITOLISIB inhibitor
- BUPARLISIB inhibitor
- AZD-6482 inhibitor
- RECILISIB inhibitor
- TG100-115 inhibitor
- SF-1126 inhibitor
- TASELISIB inhibitor
- PILARALISIB inhibitor
- VS-5584 inhibitor
- GSK-1059615 inhibitor
- BGT-226 inhibitor
- VOXTALISIB inhibitor
- PAXALISIB inhibitor
- EGANELISIB inhibitor
- SONOLISIB inhibitor
- SAMOTOLISIB inhibitor
- TENALISIB inhibitor
- PUQUITINIB MESYLATE DIHYDRATE inhibitor
- PANULISIB inhibitor
- PICTILISIB inhibitor
- DUVELISIB MONOHYDRATE inhibitor
- ZSTK-474 inhibitor
- GEDATOLISIB inhibitor
Related proteins · sequence + function similarity
- Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform 0.99
- Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform 0.99
- Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform 0.93
- Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform 0.92
- Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform 0.91
- Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform 0.89
- Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform 0.89
- Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform 0.89
- Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform 0.89
- Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform 0.84
- Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform 0.81
- Phosphatidylinositol 3-kinase catalytic subunit type 3 0.74
Co-cited proteins · studied together in the literature
- Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform 4 shared papers
- Tropomyosin beta chain 1 shared papers
- Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform 2 shared papers
- Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform 2 shared papers
- Phosphoinositide 3-kinase regulatory subunit 5 1 shared papers
- Inositol polyphosphate multikinase 1 shared papers
- Phosphatidylinositol 4-kinase beta 1 shared papers
- Phosphoinositide 3-kinase regulatory subunit 6 1 shared papers
- Phosphoinositide 3-kinase regulatory subunit 6 1 shared papers
- cGMP-inhibited 3',5'-cyclic phosphodiesterase 3B 1 shared papers
- cGMP-inhibited 3',5'-cyclic phosphodiesterase 3B 1 shared papers
- Inositol polyphosphate multikinase 1 shared papers
Literature · 22 cited papers
- Germline biallelic PIK3CG mutations in a multifaceted immunodeficiency with immune dysregulation. Haematologica · 2020
- Human PI3Kgamma deficiency and its microbiota-dependent mouse model reveal immunodeficiency and tissue immunopathology. Nat. Commun. · 2019
- A phosphodiesterase 3B-based signaling complex integrates exchange protein activated by cAMP 1 and phosphatidylinositol 3-kinase signals in human arterial endothelial cells. J. Biol. Chem. · 2011
- Initial characterization of the human central proteome. BMC Syst. Biol. · 2011
- Cardiac regulation by phosphoinositide 3-kinases and PTEN. Cardiovasc. Res. · 2009
- Targeting phosphoinositide 3-kinase gamma to fight inflammation and more. Thromb. Haemost. · 2008
- PI3K delta and PI3K gamma: partners in crime in inflammation in rheumatoid arthritis and beyond? Nat. Rev. Immunol. · 2007
- Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. Nat. Med. · 2005
- Inositol polyphosphate multikinase is a nuclear PI3-kinase with transcriptional regulatory activity. Proc. Natl. Acad. Sci. U.S.A. · 2005
- Protein kinase activity of phosphoinositide 3-kinase regulates beta-adrenergic receptor endocytosis. Nat. Cell Biol. · 2005
- p84, a new Gbetagamma-activated regulatory subunit of the type IB phosphoinositide 3-kinase p110gamma. Curr. Biol. · 2005
- The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. · 2004
- … and 10 more in the literature graph